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Justin Krogue brought along his son,
1-year-old Miles (dressed in baby-sized
scrubs), and wife, Marissa, to Match Day
festivities March 20 in the Eric P. Newman
Education Center. The envelope contained
big news: The family will relocate to the
University of California, San Francisco, where
Justin will train in orthopedic surgery. To
learn the fate of more than 120 transitioning
School of Medicine students, see page 24.
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Researchers at the School of
Medicine and the Auburn University College of
Veterinary Medicine in Alabama are working
together to develop cancer therapies for
people and their animal companions. The
researchers have collaborated for 20 years in
an effort to make viral-based cancer
treatments a reality for both dogs and people.
To learn more about this human-animal
connection, see page 12.
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This unwelcome
visitor, the Aedes
aegypti mosquito,
comes bearing
Chikungunya.

Airborne invasion

Arthritis-like virus makes its way to U.S. via a tropical mosquito

E

very mosquito season brings with
it the fear that these annoying
insects could arrive carrying a
dangerous disease. One such infection has
recently been detected in the U.S.
Known as Chikungunya, an African word
for “that which bends up,” this mosquitoborne virus causes arthritis-like symptoms.
The virus is mainly spread by the tropical
Aedes aegypti mosquito and first was identified 60 years ago in eastern Africa. Since
then, it has spread across the world.
In 2014, more than 2,000 people in the
U.S. developed the infection after traveling
abroad, mostly to the Caribbean. That same
year, 11 cases of Chikungunya infection
were reported among people living in
Florida who had not traveled outside the
U.S., suggesting that mosquitoes in that
state were spreading the virus.
In most patients, the infection causes a
fever, rash and severe joint pain. The fever
2
2 Washington
Washington University
University School
School ofof Medicine
Medicine

and rash typically subside in seven to 10 days,
but symptoms of arthritis may persist in up to
60 percent of patients for a year or longer.
Researchers at Washington University
School of Medicine have found that blood
tests of patients carrying the Chikungunya
virus and those with rheumatoid arthritis can
produce similar results. This may lead to the
misdiagnosis of some patients with the virus.
The findings underscore the need for
doctors to obtain detailed travel and medical
histories from patients being evaluated for
rheumatoid arthritis. Such details could help
distinguish between the two conditions.
The global spread of the Chikungunya
virus suggests that the disease is likely to
provide a diagnostic challenge in the years
ahead. Physicians treat rheumatoid arthritis
with drugs that suppress the immune system, but it’s not yet known whether that
approach will help or harm patients with
Chikungunya virus.

“We’re anticipating that Chikungunya
virus will spread broadly in the U.S., so it’s
important to develop better tools for diagnosis, prevention and treatment,” said
Deborah J. Lenschow, MD, PhD, a rheumatologist involved in the research. Researchers
here have established an online
Chikungunya registry.

Online registry for
Chikungunya cases

Global incidence of
Chikungunya as of
Spring 2015
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Shapiro’s legacy
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Larry J. Shapiro, MD, has announced he will step down as
executive vice chancellor for medical affairs and dean of the
School of Medicine.
Shapiro, who has led the school for nearly 12 years, will
continue at the helm until a national search is conducted and
his replacement found.
Chancellor Mark S. Wrighton is chairing the search
committee, which includes the provost, university trustees,
School of Medicine department heads and others.
Wrighton, referring to Shapiro as “St. Louis’ physician-inchief” and a leader devoted to the university and medical school,
said it is impossible to recount all of Shapiro’s achievements.
“Larry has done a terrific job in every respect: The school
has never been stronger, and he has done fabulously well
in recruiting outstanding department heads and faculty;
recruiting the most outstanding medical students; and building an outstanding and large clinical program, including
development of the Alvin J. Siteman Cancer Center.
“He was instrumental in launching the Institute for Public Health
and supporting its development,
and he played a lead role in enhancing the school’s educational mission
and in strengthening the quality
and impact of research.”
Shapiro said his leadership role
at the university “has been the
utmost privilege of my professional
Larry J. Shapiro, MD
career and has provided me with
challenges, great satisfaction and much happiness.”
A pediatric geneticist by training, Shapiro is a
Washington University legacy. He first arrived in St. Louis
50 years ago as an undergraduate student in Arts & Sciences.
He then pursued his medical degree at the School of
Medicine and completed his residency at St. Louis Children’s
Hospital in 1973.
Afterward, he embarked on a medical career at the
National Institutes of Health (NIH) and then at the
University of California, Los Angeles, and the University
of California, San Francisco. He returned to St. Louis in
2003 as a renowned genetics researcher, administrator and
pediatrician. That year, he took on the roles of executive
vice chancellor for medical affairs, dean of the School
of Medicine and the Spencer T. and Ann W. Olin
Distinguished Professor.
He is also president of Washington University Medical
Center, which includes the School of Medicine, Barnes-Jewish
Hospital and St. Louis Children’s Hospital.
outlook.wustl.edu
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‘Chief physician’ stepping down

Sparking interest

The Office of Diversity Programs
annually selects 50 students from St. Louis City and County high
schools to participate in a four-week human anatomy and physiology
course taught by Will Ross, MD, MPH, associate dean for diversity,
along with medical students. At the program’s end, the high school
students present on a medical topic that they have researched using
the Internet and library resources, with the assistance of the Bernard
Becker Medical Library staff. The program seeks to improve diversity
in the future medical and scientific workforce.

Study may aid stroke recovery
Stroke can lead to a wide range of problems such as depression and difficulty moving, speaking and paying attention.
Scientists have thought these issues were caused by damage
to the brain’s “computer processors” — cells in the brain’s
outer layer that do much of the work involved in higher
brain functions.
But a new study by School of Medicine
researchers has found compelling evidence
that stroke damage to “cables” buried inside
the brain plays an important role in these
impairments. The cables connect cells on
the brain’s surface to each other, to other
cells deep in the brain and to cells in the
spinal cord that link the brain to the rest
of the body.
“This study provides a new framework to Maurizio Corbetta, MD
think about the damage caused by stroke,”
said senior author Maurizio Corbetta, MD, the Norman J.
Stupp Professor of Neurology. “A more complete and accurate description of the most common anatomical damage
and deficits after a stroke will help us understand how the
brain can adapt to recover lost functions and potentially
lead to new rehabilitation strategies.”
To get a better sense of how stroke damages the brain,
Corbetta and his colleagues initiated a study of 132 patients
who had just suffered first-time strokes. The results appeared
online March 4 in Neuron.
Outlook 3
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Kidney cancer detected with urine test

Two named AAAS fellows School of Medicine
faculty members Mary C. Dinauer, MD, PhD, and David M. Holtzman,
MD, have been named fellows of the American Association for the
Advancement of Science. Dinauer is the Fred M. Saigh Distinguished
Chair in Pediatric Research at St. Louis Children’s Hospital and professor of pediatrics and of pathology and immunology. Holtzman
is the Andrew B. and Gretchen P. Jones Professor and head of the
Department of Neurology.

Start of ‘post-antibiotic’ era?
Antibiotic resistance is poised to spread globally among
bacteria implicated in respiratory and urinary infections
in hospital settings, according to new research.
Two genes that confer resistance
against a particularly strong class of
antibiotics can be shared among a
family of bacteria responsible for a
significant portion of hospitalassociated infections, the study shows.
Drug-resistant germs recently
infected several patients at two Los
Angeles hospitals. The infections have
‘Superbugs’ pose a threat
been linked to medical scopes possibly
contaminated with bacteria resistant
CENTERS FOR
DISEASE CONTROL
to carbapenems, potent antibiotics for use only in gravely
ill patients or those infected by resistant bacteria.
“Carbapenems are one of our last resorts for treating
bacterial infections, what we use when nothing else works,”
said senior author Gautam Dantas, PhD, associate professor
of pathology and immunology. “Given what we know now,
I don’t think it’s overstating the case to say that for certain
types of infections, we may be looking at the start of the
post-antibiotic era, a time when most of the antibiotics we
rely on to treat bacterial infections are no longer effective.”
Dantas and others recommend limiting the usage of
carbapenems to cases in which no other treatments can help.
The study, conducted by researchers at Washington
University, Barnes-Jewish Hospital and the National
Enjoy interactive elements and added content
University of Sciences and Technology in Pakistan, is
available online in Emerging Infectious Diseases.
4 Washington University School of Medicine

School of Medicine researchers have developed a noninvasive
method to screen for kidney cancer that involves measuring the presence of proteins in the urine. The findings are
reported March 19 in the journal JAMA Oncology.
The researchers found that the protein biomarkers were
more than 95 percent accurate in identifying early-stage
kidney cancers. In addition, there were no false positives
caused by non-cancerous kidney disease.
“These biomarkers are very sensitive and specific to kidney cancer,” said senior author Evan D. Kharasch, MD, PhD.
Like most cancers, kidney tumors are easier to treat when
diagnosed early. But symptoms of the disease, such as blood
in the urine and abdominal pain, often don’t develop until
later, making early diagnosis difficult.
“The most common way that we find kidney cancer is as
an incidental, fortuitous finding when someone has a CT
or MRI scan,” said Kharasch, the Russell D. and Mary B.
Shelden Professor of Anesthesiology. “It’s not affordable to
use such scans as a screening method, so our goal has been
to develop a urine test to identify kidney cancer early.”
With researchers from the Alvin J. Siteman Cancer
Center, the Mallinckrodt
Institute of Radiology
and the Division of
Urologic Surgery,
Kharasch and principal
investigator Jeremiah J.
Morrissey, PhD, professor
of anesthesiology, analyzed urine samples from
720 patients at BarnesJewish Hospital who were
about to undergo abdomCurrently, surgery is the only
inal CT scans for reasons
unrelated to suspicion of
way to diagnose kidney cancer.
kidney cancer.
Results of the scans let the investigators determine
whether patients might have kidney cancer. As a comparison,
they also analyzed samples from 80 healthy people and 19
patients previously diagnosed with kidney cancer.
The researchers measured levels of two proteins in the urine
— aquaporin-1 (AQP1) and perlipin-2 (PLIN2). None of the
healthy people had elevated levels of either protein, but patients
with kidney cancer had elevated levels of both proteins.
About 15 percent of kidney masses found by CT scans
are not malignant. The only way to know definitively is to
operate. Kharasch and Morrissey are using the findings to
develop an easy-to-use, more widely available screening test.
Spring 2015

Specialty center
will focus on kids

The St. Louis Children’s Specialty Care Center, scheduled to open in June 2015, is a new outpatient facility
focused exclusively on pediatric patients. Washington
University Physicians and St. Louis Children’s Hospital
pediatric nurses and staff will provide a wide range of
services at the facility, located in west St. Louis County
at Highway 40/I-64 and Mason Road.

The center is being designed as an uplifting
and creative environment that reduces stress,
promotes healing and provides a superior patient
experience. The facility also offers three operating
rooms and a variety of imaging, lab and therapy
services. Space is available for classes on CPR,
babysitting and staying home alone, among
other topics.

GENETICS

Bacterial DNA also shapes inheritance

I

t’s a firmly established fact straight from
Biology 101: Traits such as eye color and
height are passed from one generation
to the next through the parents’ DNA.
But now, a new study in mice by School
of Medicine researchers has shown that the
DNA of bacteria in the body can pass a trait to
offspring in a way similar to the parents’ own
DNA. According to the authors, the discovery
means scientists need to consider a significant
new factor – the DNA of microbes passed from
mother to child – in their efforts to understand
how genes influence illness and health. The
study appeared online Feb. 16 in Nature.
“We have kept bacteria on one side of
a line separating the factors that shape our
development — the environmental side of
that line, not the genetic side,” said co-senior
author Herbert W. Virgin IV, MD, PhD.
“But our results show bacteria stepping
over the line. This suggests we may need to
substantially expand our thinking about their
contributions, and perhaps the contributions
of other microorganisms, to genetics and
heredity.”
outlook.wustl.edu

Bacteria are known for their roles in
harmful infections. But scientists have realized that such bacteria are only a tiny fraction
of the bacterial communities that live in and
on our bodies. Most bacteria are commensal,
which means they do not cause harm and
often confer benefits.
Commensal bacteria influence traits
such as weight and behavior. But until now,
researchers thought the bacteria that exerted
these effects were acquired during a person’s
life. The study is the first to show that bacterial DNA can pass from parent to offspring in
a manner that affects specific traits such as
immunity and inflammation.
The researchers linked commensal bacteria
in mice to gut injury susceptibility. Mice with
certain inherited bacteria are susceptible to
the injury, which is caused by exposure to a
chemical. Female mice pass the bacteria to
their offspring, making them vulnerable to
the injury. Others carrying different bacteria
are less susceptible.
In the short term, the findings may help
scientists eliminate a significant “bug” in stud-

ies of genetically engineered mice. In several
fields of research, scientists have been confronted intermittently with the sudden, unexplained appearance of new or altered traits in
mice. The traits often spread from one mouse
habitat to the next, suggesting a spreading
microbial infection is responsible. But the
traits also consistently pass from mother to
offspring, suggesting a genetic cause.
In the long term, Virgin expects the
expanded model of heredity to produce
a more complicated but also much more
insightful picture of how human, bacterial
and viral genes influence human health.
Outlook 5
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Targetings colds, COPD and more

In the spotlight Recipients of the 2014 2nd Century
Awards: (from left) Scott J. Hultgren, PhD, Carol B. Loeb and
F. Sessions Cole, MD. The 2nd Century Awards recognize those whose
long-term commitment and participation have helped the School
of Medicine enter its second century with strength and confidence.
Hultgren was honored for research focused on microbial-host
interactions and his work on how infectious diseases are diagnosed,
treated and prevented. Loeb was honored for personal and professional dedication to the advancement of education. Cole was
honored for achievements in improving outcomes for newborns.

ROBERT BOSTON

Evaluating long-acting birth control
New research indicates that hormonal intrauterine devices
(IUDs) and contraceptive implants remain highly effective
one year beyond their approved duration of use, according
to a School of Medicine study. The preliminary findings
are reported in Obstetrics & Gynecology.
Researchers are evaluating whether
such long-acting forms of birth control
are effective for up to three years past the
length of use approved by the Food and
Drug Administration (FDA). Contraceptive
implants — matchstick-sized rods inserted
into the arm — are approved for three
years, and hormonal IUDs are approved
for five years. Extended use of these devices
Demonstrating a hormonal
reduces cost to individuals and insurers,
intrauterine device (IUD)
said first author Colleen McNicholas, DO,
assistant professor of obstetrics and gynecology.
These long-acting contraceptive methods are garnering
renewed attention in the U.S. because of their superior
effectiveness over other forms of birth control. The study
aims to enroll a total of 800 women.
“In the long term, this work has the potential to
change how we provide contraceptive methods around the
world and can enable women to control their reproductive
health and family size,” said senior author Jeffrey Peipert,
Enjoy interactive elements and added content
MD, PhD, the Robert J. Terry Professor of Obstetrics
and Gynecology.
6 Washington University School of Medicine

A Washington University drug discovery program has
received three grants totaling more than $5 million from the
National Institutes of Health (NIH) to develop new therapeutics for respiratory diseases. The target illnesses range
from the common cold to life-threatening lung disease.
The projects include designing next-generation drugs
to open the airway passages by controlling mucus production, as well as new agents to fight off respiratory infections
by boosting the immune system. The program, based in
the Division of Pulmonary and Critical Care Medicine in
the Department of Medicine, is led by pulmonologist and
principal investigator Michael J. Holtzman, MD, the Selma
and Herman Seldin
Professor of Medicine.
“Chronic respiratory
disease is the thirdleading cause of death
in the U.S. and the fifth
worldwide, and these
deaths are linked most
strongly to overproduction of inflammatory
mucus that blocks the
airways,” he said. “The
pathway to mucus production is invariably
activated in respiratory
viral infections, and
The research holds
the same process drives exacpromise for developing
erbations and progression of
a range of therapies.
chronic respiratory diseases
like asthma and COPD, yet
there are no drugs that effectively control this pathway.”
The largest award, totaling just over $3 million,
will support a project focused on optimizing a chemical
compound Holtzman’s group developed to block a key
checkpoint in the mucus pathway.
Two other awards totaling $2.5 million will address the
need to control viruses that drive acute and chronic respiratory disease. These awards are designed to develop the next
generation of antiviral drugs. There is a crucial need for
drugs that battle common viruses that cause respiratory
illness. To address this issue, Holtzman’s group came up
with a strategy to improve the body’s interferon signaling
pathway, the main means for antiviral defense.
The Drug Discovery Program, in its fourth year
of operation, is envisioned as a model for academic
development of new therapeutics.
Spring 2015
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Clinical studies begin on a tiny technology
that could pinpoint arterial disease risks
BY JULIA EVANGELOU STRAIT
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A new nanoparticle-based imaging agent

biomedical engineering. “Starting with bench research,

In patients with atherosclerosis, plaque accumulates on the inner walls of arteries, which
deliver blood to the body. In many cases, the accumulated plaque causes no symptoms and remains
undiagnosed by physicians. Plaque accumulation
eventually can narrow an artery enough to cause
chest pain or mild symptoms. But, for some, this
plaque suddenly can rupture without warning,
create blockages and cause a heart attack or stroke.
“Plaque is a complex structure, made up of cholesterol, calcified deposits and other substances,
all of which can cause plaque instability,” said
Woodard, also director of the Center for Clinical
Imaging Research (CCIR) at the Mallinckrodt
Institute of Radiology at Washington University.
“This imaging agent targets a specific receptor
that is present in more vulnerable complex plaque,
thereby identifying which plaques might rupture
in the patient, leading to stroke or heart attack.”
Past research shows most patients with plaque
narrowing a carotid artery will not go on to have
a stroke.

then developing and testing the agent and taking

Distinguishing high-risk patients

may help identify patients at high risk of stroke by
revealing dangerous plaque in arteries. The Food and
Drug Administration (FDA) has approved the agent
for investigational use in people. The technology was
jointly developed at Washington University School
of Medicine and the University of California, Santa
Barbara, in collaboration with Texas A&M University.
“This is the first receptor-targeted nanoparticle
agent for cardiovascular imaging approved for investigational use in humans,” said principal investigator
Pamela K. Woodard, MD, professor of radiology and of

it through the FDA process into human patients has
involved an extensive team of basic scientists, clinical
researchers and clinicians.”

ROBERT BOSTON

Pamela K. Woodard, MD

8 Washington University School of Medicine

“With current technology, such as ultrasound,
we can’t tell whether the plaque is vulnerable
or stable,” she said. “So we can’t distinguish
the high-risk patients who need surgery from
low-risk patients who can be treated with
medication alone.
“We designed this nanoparticle agent to
develop a test that can detect these vulnerable
plaques and identify those patients at highest
risk of stroke and in need of surgery to remove
the plaque.”
Gregorio A. Sicard, MD, vascular surgeon and
professor of surgery and of radiology, said specialists who treat carotid artery disease have been
seeking a diagnostic test that could identify extracranial carotid artery disease, which is more prone
to embolize, rupture or occlude the carotid artery.
These types of vulnerable plaques are more likely
to cause an embolic cerebral vascular event with
devastating effects. In many cases, these patients
are asymptomatic.
“This exciting work by Dr. Woodard and
collaborators may provide a screening imaging
study that will identify, in asymptomatic patients,
those that have a vulnerable plaque and are therefore more likely to have a cerebral vascular event,”
Sicard said. “This cutting-edge diagnostic study
hopefully will revolutionize the management of
patients with asymptomatic carotid plaque and
plaque in other arterial beds.”
Spring 2015

PEPTIDES

BLOODSTREAM

Miniaturized medicine
The nanoparticle-based imaging agent carries custom
peptide molecules that bind to the receptors of unstable
plaques. First, the peptides are attached to nanoparticle
“combs,” left, which morph into star-like shapes when wetted.
Injected into the bloodstream, legions of these stars descend
on dangerous plaques, shining brightly on radiologic images.

How it works

The nanoparticle is unique in how it is targeted,
according to Yongjian Liu, PhD, assistant professor of radiology and co-investigator on the project.
Previous research demonstrated that a receptor
called NPR-C is present on the surface of cells
that line blood vessels and is increased in plaque
associated with atherosclerosis. So the investigators added a small peptide to the nanoparticle.
That peptide seeks out and binds to NPR-C,
specifically targeting the particle to potentially
dangerous plaque.
The nanoparticle also carries copper atoms,
making it visible with a standard positron emission tomography (PET) scanner. Similarly, small
amounts of copper-64 are used in PET scans for
cancer detection and therapy and neurologic
imaging. Once injected, this nanoparticle agent
can illuminate potentially vulnerable plaque in
the body’s arteries.
The carrier nanoparticle was crafted in the
lab of Craig J. Hawker, PhD, professor and
director of the California Nanosystems Institute
at the University of California, Santa Barbara.
“We couldn’t carry out the research without his
contributions,” Woodard said.
Following successful tests in animal models,
researchers recently began testing the safety of
the nanoparticle in healthy individuals. Next,
outlook.wustl.edu
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ARTERIAL PLAQUE

they will focus on patients with atherosclerosis
who already are scheduled to undergo surgery
to remove plaque from their carotid arteries.
Testing of these patients will begin in a novel
PET-MR system housed in the CCIR, so that the
researchers can look at plaque anatomy on MRI
and PET signals from the new agent concurrently.
“We’ll be able to see whether the areas that
light up in the image because of our nanoparticles
are the same areas that contain vulnerable plaque,
as assessed from the surgeries,” Woodard said.
Once the investigators demonstrate success
imaging the carotid arteries, they will evaluate the
nanoparticle agent in other vessels such as the coronary arteries, which represent a greater challenge
because of their smaller size and complex motion.
“Given the clinical success of this agent,
with the assistance of the Office of Technology
Management, we have begun seeking to advance
this imaging agent into a commercial product,”
Woodard said.
“We have been able to develop this highly
receptor-specific imaging technology because of
the generous support from the National Heart,
Lung and Blood Institute, our diverse and dedicated team of investigators and our extensive
facilities at Washington University,” she added.

The Center for Clinical
Imaging Research provides
advanced imaging resources
and support for clinical
investigators.
LEARN MORE
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Alumna Melanie Paticoff,
MSDE ’13, with her mentor
Heather Hayes, PhD, director
of deaf education studies in
the Program in Audiology and
Communication Sciences.

Celebrating differences

T

oday, as a result of newborn hearing screenings,

Kids with hearing loss must
overcome obstacles beyond the
usual struggles growing up.
One impassioned alumna
is providing an uplifting
resource worldwide.

advanced technologies and early intervention
programs, more and more children with hearing loss

are being mainstreamed into classrooms alongside hearing
peers. With individualized support and assistive devices, such
as cochlear implants, these children thrive academically. But,
though they may excel in speech and listening, often, they
feel socially isolated. n Alumna Melanie Paticoff is working
to help them combat these feelings, providing a point of
connection for kids and teens with hearing loss around the

BY DEB PARKER

world. Last year, she launched Hearing Our Way, the only
such magazine for children and teens. The goal: Bring hearingimpaired young people together through shared experiences.

10 Washington University School of Medicine
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Closing a gap

Growing up in Long Island, New York, Paticoff
was inspired by her cousin Julie, now 19. As
Paticoff explains, Julie listens to her iPod, attends
concerts and is a member of a dance team. She
also is profoundly deaf. Bilateral cochlear implants
give her complete access to sound.
“There are 3 million other kids in the U.S.
just like Julie and millions more around the
world,” Paticoff said. “They attend school with
their friends, join clubs and play sports, but
they are usually the only ones with hearing
loss in their entire school district.”
Often, these children haven’t spent any
time in schools for the deaf and have had little
exposure to other kids with hearing loss.
While pursuing degrees in deaf education,
Paticoff witnessed a gap in social and emotional
support for children with hearing loss. She
noticed, for example, that children’s literature
rarely depicts characters with hearing loss. This
inspired her to write and self-publish two awardwinning children’s books featuring Sophie, a
fictional dog with a cochlear implant — “Sophie’s
Tales: Learning to Listen” (2010) and “Sophie’s
Tales: Overcoming Obstacles” (2012).
In 2011, Paticoff earned a bachelor’s degree in
deaf education from Fontbonne University and, in
2013, a master’s degree from Washington University’s
Program in Audiology and Communication
Sciences (PACS), where she received the Max A.
Goldstein Award for outstanding academic
achievement and professional promise.
“Melanie was a special student from the very
beginning,” said Paticoff’s mentor Heather Hayes,
PhD, director of deaf education studies.
“Her drive to help children who are deaf and
who learn to listen and talk was unparalleled.
It was my distinct pleasure to be one of her
mentors, and I take great pride in it still.”

Reaching out

After graduating in May 2013, Paticoff began
developing the magazine that summer. The
first issue arrived in homes a year later, and a
successful crowdfunding campaign followed.
The quarterly magazine, which includes
inspirational stories, language tips and tricks,
self-advocacy skills and interviews with teens
who have faced similar obstacles, is offered free.
“The magazine teaches kids and teens to
celebrate their differences and provides vital
social and emotional support to young people
during their formative years,” Paticoff said.
outlook.wustl.edu

Filled with positivity and pop culture references, a recent issue contained song lyrics from
the Jonas Brothers and advice on hairstyles that
work well with cochlear implants.
Five thousand subscribers signed up in the
first two months — with readers across the U.S.
and as far away as Australia and Italy. Now,
there are 10,000 subscribers.
“Melanie is reaching out to children across the
country (and the world) with her publication,”
Hayes said. “Most importantly, she’s also reaching
families, audiologists and physicians who might
not even realize how valuable a magazine like
this can be to young children and adolescents.
Just simply seeing images of children with devices
like hearing aids and cochlear implants in a fun
publication can mean the world to a child.

“Deafness is a low-incidence disability
and, thus, many children and parents struggle
to find common experiences with others.
“Additionally, Mel is bringing awareness to
others about how children who are deaf can
learn to listen and talk. This is invaluable.”
The partnership between the magazine and
the medical school is still strong nearly two years
post-graduation. PACS is a magazine sponsor, and
every issue spotlights a current deaf education or
audiology student at the medical school. A recent
issue featuring a graduate student with hearing
loss helped further illustrate that those with
hearing impairment can go on to become
audiologists, teachers or leaders in other fields.
Paticoff resides in St. Louis as editor-in-chief
of Hearing Our Way and chief executive officer
of Sophie’s Tales LLC.

Sophie, a spunky
Maltipoo that proudly
wears a purple
cochlear implant, is
based on Paticoff’s
real-life pet, a
certified therapy dog.

Reinforcing positive
experiences for hearingimpaired children
LEARN MORE

HearingOurWay.com
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Canine companions share
our lives. They even get similar
cancers. These connections
suggest a new frontier of
mutually beneficial therapies.

Shared
medicine

H U M A N S A N D D O G S have lived alongside one
another for millennia. Dogs have provided protection and
companionship, labor and love. They have worked our farms,
hunted our food, guarded our livestock, played with our kids
and evolved with us. It’s a unique relationship, unrivaled by
any other set of species. And while we may recognize many of
the mutually beneficial aspects of this bond, a new paradigm is
emerging between man and his best friend: shared medicine.
It’s no secret that animals and people share many of the
same diseases. Testing possible treatments for people on animals,
especially laboratory mice, is a mainstay of medical
An experimental cancer therapy
research and the origin of most modern therapies.
may have benefited greyhound
But physicians are realizing how much stands to
Pretty, right, who lived more than
twice as long as the average for her
be learned by collaborating with veterinarians and
condition. Nancy Hunter learned of
designing clinical trials for animals — to treat their
the program through a web search.
naturally occurring diseases — just as we do in people.
The lesson has been embraced by Washington University’s
David T. Curiel, MD, PhD, a professor of radiation oncology and
of cancer biology. Much of Curiel’s research focuses on the use
of engineered viruses to treat disease, especially cancer. He and
veterinarians at Auburn University in Alabama are cultivating
partnerships they hope will speed the development
of cancer therapies for people and their animal companions.
“People love their pets and want to treat them when they
get cancer,” Curiel said. “And dogs get cancers that
are very similar to human cancers.”

BY JULIA
EVANGELOU
STRAIT
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Bruce F. Smith, VMD, PhD,
of Auburn University College
of Veterinary Medicine,
collaborates with researchers
at Washington University
School of Medicine in
pursuit of virus-based cancer
treatments that could benefit
dogs as well as humans.

It started with a limp.

Greyhound Gary’s
dedicated owners
quickly responded
to the signs that he
could have cancer.

At first, Dawn Oravetz thought her rescue greyhound Gary had simply tripped and bruised his
right rear leg. Or, at age 10, perhaps some arthritis
was developing in his joints, especially since Gary
had spent his early life sprinting around racetracks
at 40 miles per hour. Oravetz hoped it was just a
bruise, but she had good reason to worry.
Greyhounds, especially those bred for racing,
and other large-breed dogs are at above average
risk of developing a type of bone cancer
called osteosarcoma. Osteosarcoma is
also one of the more common cancers
of human adolescence, emerging
with teenage growth spurts. In
dogs, the tumor tends to be particularly aggressive. Standard treatment is amputation of the affected
leg followed by several rounds of
chemotherapy. The tumor often
spreads to the lungs. Even with
aggressive treatment, prognosis is
poor. Greyhounds survive an average
of only nine months after diagnosis.
Oravetz and her husband, Bill, understood
this better than most, already having lost two
adopted greyhounds to the disease.
Through contacts in a local greyhound rescue
organization, Oravetz learned of a clinical trial
at Auburn’s College of Veterinary Medicine,
about a four-hour drive from their home in
Navarre, Florida.
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“We learned from past experience that you
don’t put it off,” Dawn Oravetz said. “We found
out about Gary’s tumor on a Saturday. And by
Thursday, we were at Auburn.”
The director of Auburn’s cancer research
initiative, Bruce F. Smith, VMD, PhD, has been
collaborating with Curiel for more than 20 years,
in an effort to make virus-based cancer treatments
a reality for both dogs and people.
A major barrier to research and development
of viral cancer treatments is that they cannot be
tested in traditional mouse models.
“Human adenoviruses don’t replicate in mice,”
Curiel said. “But we thought, what if we take a
virus that normally infects dogs and use it to
treat dog tumors? Now you have a virus that can
replicate in the tumor. The animals have working
immune systems and are genetically diverse.
In theory, this fully mimics what we want to
do in humans. It’s a more stringent test of the
system. And you may end up with a new therapy
for dogs in the process.”
Curiel and Smith emphasize that Gary and
dogs like him are not experimental animals. As
in people, their cancers develop spontaneously,
probably due to some interaction between genes
and environment. They don’t live in controlled
laboratory settings with identical diets. These
dogs live at home with their families. And perhaps
most importantly for this particular kind of trial,
they have intact immune systems, unlike mice so
commonly used in cancer research. In short, if a
clinical trial of an investigational therapy works
in dogs living in the real world, it may be more
likely to work in the people who live with them.
Spring 2015

Building
viral-based
therapies
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Making custom cancer-destroying viruses requires meticulous teamwork.
In the Curiel lab, that collaboration is fostered by two husband-and-wife
partnerships: Igor Dmitriev (1) and Elena Kashentseva (3), and Sergey
Kaliberov (2) and Lyudmila Kaliberova (4), all Russian émigrés who
brought their scientific skills to Washington University School of Medicine.

The process begins with a procedure
that reprograms viral DNA so it can
target cancer cells.

A whirl in the centrifuge separates the virus
from the packaging cells. Testing reveals bands
of pure virus (see arrows at edge of this page).

outlook.wustl.edu
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4

Specialized packaging cells house the virus,
supply necessary cellular functions and allow
the virus to grow and multiply.

Finally, the scientists verify that the new
batch of virus will spare healthy cells and
kill tumor cells when used in clinical trials.
Outlook 15

The engineered virus is injected
into the dog, infects and replicates
in tumor cells and kills them before
spreading to repeat the cycle.

Virus:
Surface
detail

TUMOR

Racing greyhounds
are at greater risk
for osteosarcoma,
a fast-moving bone
cancer that often
strikes human
adolescents.

Infect

ERIC YOUNG / MEDICAL PUBLIC AFFAIRS

Making cancer
destroy itself

TUMOR CELL

Replicate

Destroy

Spread

As with clinical trials for people, which are
voluntary, participation in this trial is at the
discretion of the pet owners. Similar to human
trials, clinical trials involving animals are overseen and approved by an independent committee
that reviews the protocol and decides whether
all requirements for ethical disclosure are met.

While the concept of uniting

human and veterinary medicine is not new —
most recently dubbed the One Health or One
Medicine movement — it is beginning to gain
new traction in the human medical community.
The initiative received a boost in 2012 with the
publication of The New York Times bestselling
book “Zoobiquity: The Astonishing Connection
Between Human and Animal Health.” In it,
Barbara Natterson-Horowitz, MD, and co-author
Kathryn Bowers argue for increased collaboration
between physicians and veterinarians.
Natterson-Horowitz, a cardiologist at the
University of California, Los Angeles, noted that
veterinarian colleagues at the Los Angeles Zoo
often consult human doctors and the medical
literature for insights into how best to treat
their animal patients. But the reverse — human
doctors seeking the collective wisdom of animal
doctors and their flagship journals — is a rarity,
the authors observed.
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In the spirit of shared medicine, Curiel
and Smith have developed a trial using a modified version of a common canine virus to treat
canine osteosarcoma. Curiel, who also directs
Washington University’s Biologic Therapeutics
Center, and his team in St. Louis manufacture the
viral vectors, freeze them and ship them to Smith.
The therapeutic virus can infect any cell in
the body, but it is engineered to replicate in bone
tumor cells. Curiel explains bone tumor cells
contain a genetic “on” switch required to set the
altered virus’s replication machinery into action.
Once the virus infects a bone tumor cell, which
flips the switch, the virus begins replicating,
filling up the cell and causing it to explode.
“We turn the cancer cell into a factory of its
own destruction,” Smith said. “Rupturing the
cell also sets loose more viruses that are now
free to infect other cells.”
To determine if the virus is working as designed,
the researchers plan to involve 20 dogs, including
Gary, in the current trial. Four dogs participated
in a previous, smaller trial to test the safety of
the viral treatment, much like human clinical
trials start with a phase 1 safety trial. According
to Smith, the experience of one dog in particular
laid the groundwork for the current trial.
In late 2006, Nancy Hunter noticed the telltale limp in her rescue greyhound, Pretty. After
receiving the osteosarcoma diagnosis, Hunter
scoured the Internet and found information about
Spring 2015

the investigational viral treatment available at
Auburn. Pretty had the affected leg amputated,
received the viral treatment and later underwent
chemotherapy.
“She handled the treatment really well,” Hunter
said. “After recovering from the surgery, she went
back to digging in her sand pile, running around
the yard and taking long walks. She got around
great on three legs.”
At one year, when Hunter took Pretty for
follow-up X-rays, the vets saw two spots on her
lungs and suspected the cancer had spread. Upon
further analysis, the lesions were determined to
be scar tissue. Most significantly, these lesions
were possible evidence of an acquired immune
response to the tumor.
In addition to rupturing tumor cells with
replicating viruses, the treatment may prime the
dogs’ immune systems to recognize and attack
the virus-infected cells.
“If that is the case, we may be creating an environment that could allow the immune system to
start recognizing tumor cells and mount an antitumor immune response,” Smith said. “In other
words, we’re trying to find out if the dogs become
vaccinated against a recurrence of the tumor.
That’s the question we want to answer in the
current, larger trial.”
Pretty ultimately lived two years and four
months after diagnosis, more than twice as long
as the average. Smith said there’s no way to know
if the experimental treatment was responsible for
this. But Pretty’s experience and that of the other
three dogs in the first trial allowed them to get
funding for the current one.
Very early evidence suggests that a subset of
dogs responds well to the treatment. The rest
follow the average course. Curiel compares this
to human treatments in which only a subset of
patients responds well, pointing to the importance
of personalized or precision medicine.

cancer. Partnering with more veterinarians,
including some at the University of MissouriColumbia, Curiel is working to begin canine trials
to test viral therapies in canine melanoma and
lymphoma. He is also working with breast cancer
researchers to look for ways to improve an investigational vaccine against human breast cancer.
As for Gary, he finished chemotherapy Jan. 30
and is doing well. Four months post-diagnosis, his
chest X-rays were clear of signs of tumor spreading. It’s too early to say whether this new treatment has helped, but the Oravetzes are optimistic.
“He’s doing so well, there are times when I forget he has cancer,” Dawn Oravetz said. “I just see
my loving, energetic, three-legged greyhound.
“With osteosarcoma so common in the greyhound community, I think a lot of owners are
willing to participate in trials like this,” she added.
“But what really geared me toward wanting to do
the study was the idea that what they learn from
the greyhounds could potentially help kids with
osteosarcoma. If what they learn from Gary could
help children with this cancer, I just think that’s
an awesome thing.”

Beyond osteosarcoma,
other cancers in dogs mimic
human disease. These
also could point toward
improved therapies.

David T. Curiel, MD, PhD
David T. Curiel,
MD, PhD

W
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“

e all want the silver bullet,” Smith said.
“But the reality is that cancer is very
diverse. This is another reason clinical trials in dogs are excellent models for human
studies. All the dogs have different immune systems. They all respond to the world in different
ways, just as people do.”
According to Curiel, several other cancers
in dogs are excellent mimics of human disease,
including melanoma, lymphoma and prostate
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Surgery’s seismic
shift from timeto competencybased training

OR
prep
B Y D E B PA R K E R
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F O R 10 0 Y E A R S ,
general surgeons have learned their craft in exactly the
same way. As residents, they spent most of their waking
(and non-waking) hours in the hospital, shadowing
more experienced surgeons and jockeying for time
in the O.R. There was no academic curriculum per se;
the patient mix dictated the day’s lesson plan. The
“apprentice” model has remained largely unchanged.
This broad-based surgical field and its proliferation
of increasingly sophisticated tools and techniques —
combined with a U.S. mandate for reduced residency
training hours — is making learning by osmosis all
the more challenging. The ever-expanding body of
knowledge is staggering; the time to learn it has shrunk.
As a result, nationally, general surgical education
is in the midst of transformation. “The next five years
will look nothing like the last 50,” explained Michael
M. Awad, MD, PhD, assistant professor of surgery and
associate dean for medical student education.
At the institutional and national levels, Washington
University educators are devising improved methods
to teach surgical skills. Consistently, School of Medicine
faculty members have been ahead of the curve in
surgical education — crafting a curriculum, employing
skills labs outside the O.R., implementing quantitative
evaluation measures and designing customized
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experiences for residents.

TIM PARKER

Residents refine their
laparoscopic techniques in
the skills lab. As testament
to the program’s strength,
School of Medicine residents
have won the national Top
Gun skills competition three
of the last four years.

F E W E R training hours

A number of factors over the past 10 to 15 years
have altered the training landscape. Declining
clinical reimbursements require doctors to see
more patients to make the bottom line, allowing
less time to teach. And residents are spending
much less time in the hospital.
In 2003, the Accreditation Council for
Graduate Medical Education (ACGME) limited
the resident workweek to 80 hours. This mandate,
a response to patient advocacy groups, was an
effort to reduce medical errors.
“Now that residents are in the hospital less, the
‘education-by-accident’ model doesn’t work as well,”
Awad said. “We have to do education by intention.”
The reduction affects all medical residents,
but surgical training programs, in particular,
had difficulty making the switch. Research indicates a strong link between a surgeon’s operative
skill, the number of operations performed and
patient outcomes.
20 Washington University School of Medicine

“Resident graduates today voice a concern about
their lack of preparedness for independence,” said
Timothy J. Eberlein, MD, chair of the Department
of Surgery and surgeon-in-chief at Barnes-Jewish
Hospital. “Not long after the introduction of an
80-hour workweek, there was a national increase in
the percent of residents failing the certifying examination of the American Board of Surgery.”
Due to medicolegal concerns, the ACGME
restrictions tightened again in 2010, calling for
greater supervision of physicians-in-training.
Interns now must be directly supervised when performing a critical portion of any procedure.
In the past, surgical trainees became increasingly autonomous during residency, gaining the
necessary expertise for independent practice.
“Before, you could do five years of residency
and hang your shingle,” Awad explained.
Today, however, most aspiring general surgeons
undertake one to three years of post-residency
fellowship training to strengthen skills and specialize.
Spring 2015

G E N E R A L gets specialized

“General surgery” and “specialization” might
seem like a contradiction in terms, but the field’s
scope is so wide, it’s virtually impossible to
master all aspects.
General surgery encompasses the abdomen,
breast, skin and soft tissue, the endocrine system,
transplants, pediatric surgery, critical care, surgical oncology (including head and neck surgery),
emergency surgery, the alimentary tract (including
bariatric surgery) and vascular surgery.
“The public also drives the push for specialization,” Awad said. “If you’re getting your hiatal hernia repaired, do you want to go to someone who
does two or three a year, along with thyroid and
gallbladder procedures, or do you want to go to
someone who does 100 of these operations a year?”
Additional, specialized training time is
needed, according to a 2013 study in the Annals
of Surgery. Awad partnered on the multi-institutional study in which U.S. fellowship directors
assessed the preparedness of general surgery
residents after completing nine years of training
(medical school and residency).
The result: 30 percent of fellowship directors
felt that those entering fellowship could not
independently perform a gallbladder removal,
19 percent felt that incoming fellows could
not sufficiently operate laparoscopic tools and
56 percent felt they could not perform laparoscopic suture techniques.

Nationally, schools
are moving away
from “one-size-fitsall” programs, instead
customizing for

T E C H N O L O G Y revolution

These percentages perhaps further underscore the
breadth of general surgery and the dizzying array of
laparoscopic, endovascular and robotic techniques.
The push for better patient outcomes has
fostered ever-more-minimally invasive procedures.
There used to be one way to remove a gallbladder
— through a five-inch abdominal incision; now
there are at least three ways.
At a recent Washington University MiniMedical School session geared for the general
public, audience members gasped in unison as
they watched a video of a surgeon removing
an appendix — through the patient’s mouth.
By passing surgical instruments and a tiny camera
through a natural opening in the body, the surgeon is able to perform incisionless procedures.
However, it’s not entirely out-with-the-old
and in-with-the new. Surgeons must be prepared
to operate the old-fashioned way if complications
develop, despite less practice with these procedures.

Video of the Top Gun
competition
wumcnews.org/topgun

C R I T I C A L shor tage

The complexity and added debt and training time
have made general surgery a less attractive career
option for medical students, who may prefer to
match to a non-surgical specialty right out of
school. “The average medical student is no longer
the single male who spends 168 hours a week at the
hospital,” Awad said. “People want a life and families. Arguably, that makes for a more well-rounded
person and doctor.”
In 2003, general surgery nationally had a
number of unfilled residency positions in the
Main Residency Match; this, combined with
unfilled spots in 2002, served as a wake-up call.
The country continues to face a general surgeon
shortage, particularly in rural areas. Almost half
of U.S. counties have no general surgeons.
“It was of concern,” said Mary E.
Klingensmith, MD, the Department of
Surgery’s vice chair for education and the Mary
Culver Distinguished Professor of Surgery.
“We realized that change was needed to bring
the best and brightest to our field to ensure a
stable workforce for the future.”

individual aspirations.
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“The academy model has
revolutionized my education.
achieve the same competencies
much more quickly in this
streamlined and personalized
approach.”

ASHLEY M. HOLDER, MD

T I M E for change

Residents win national
quiz competition
wumcnews.org/quiz

Anticipating many of these pressures, Washington
University leaders have been retooling the training
regimen and implemented an 80-hour workweek
at the medical school before the mandate.
“The ACGME adjusts its rules frequently,
often giving advance notice of planned changes,”
explained Paul Wise, MD, general surgery residency
program director. “Here, we use ‘future’ regulations
as our guide. We are a very proactive, progressive,
almost risk-taking program as opposed to many
more conservative programs that wait to let others
sort out what will and won’t work.”
With prototype programs in place, the medical
school is well poised to lead the national discussion about how best to train future surgeons.
Klingensmith directs a consortium of eight U.S.
surgical organizations, known as SCORE, which
collaborate to develop a unified training curriculum, something that previously did not exist.
The web-based curriculum is updated annually.
“We look at the technological advances and ask,
‘Is that a standard we want to make sure every
resident is learning?’” Klingensmith explained.
Nearly two decades ago, Klingensmith, a fledgling resident herself, observed as the attending
physician performed a mastectomy. Suddenly, the
attending turned to Klingensmith and said, “OK.
Close it up,” before promptly exiting the room.
“As I looked down at this young patient, I
thought, ‘You’ve got to be kidding me. I’m learning
right now,’” Klingensmith recalled. “I felt enormous pressure to make the incision look as nice
as I could. I thought if I’m ever in a position to
change surgical education, I’m going to do something about this.”
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G A I N I N G proficiency

Klingensmith, who began directing the general
surgery residency at Washington University in
2001, made good on her promise, developing a skills
training lab outside the O.R. that would expose residents to graduated levels of experience and provide
practice opportunities in a low-stress environment.
A novel concept at the time, only two other
institutions offered such labs: Southern Illinois
University-Springfield and the University of Toronto.
Washington University has made major investments in the lab, formally the WUSM Institute
for Surgical Education, accredited as a Level
1 (top) institute by the American College of
Surgeons in 2012. Awad, nurse coordinator
Debbie Tiemann, RN, and surgical technician
Angelia DeClue, RST, now administer the lab.

ROBERT BOSTON

I have witnessed that I can

Capstone, a monthlong boot camp, boosts clinical skills
as fourth-year students transition to residency. Outcomes
suggest significant increases in proficiency, and the School
of Medicine program is serving as a national example.
Spring 2015
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Tools range from low-tech plastic body parts to
highly realistic computer simulators. Students and
residents can remove a virtual gallbladder before
ever putting scalpel to flesh. Laparoscopic box
trainers test precision and speed as residents transfer rows of pegs using a video monitor as a guide.
Trainees also perform progressively challenging
procedures in animal models and human cadavers.
“There isn’t any question that working on fundamental skills translates to the operating room,”
said L. Michael Brunt, MD, professor of surgery
and chief of the Section of Minimally Invasive
Surgery and president of the Society of American
Gastrointestinal and Endoscopic Surgeons (SAGES).

I N D I V I D U A L experience

Traditionally, surgical residents have received
little formalized performance feedback.
Washington University is piloting an “academy
model” that outlines core competencies and key
milestones for several general surgery sections.
“We are moving toward competency-based
rather than time-based training,” Awad said.
The model stipulates that residents discuss
learning objectives with faculty as they begin a
rotation, receive mid-term feedback and undergo
formal assessment at the end.
To more accurately gauge trainee performance,
input is collected from nurses and technicians, as
well as faculty. Awad then meets personally with
the resident. If a resident is struggling in a particular area, he or she is paired up with a senior
resident for as long as it takes to refine the skill.
“The academy model has revolutionized my
education,” said fifth-year surgical resident Ashley
M. Holder, MD, who began training at the medical
school before the model was introduced. “I have
witnessed that I can achieve the same competencies much more quickly in this streamlined and
personalized approach.”
Another significant change nationally is a
shift away from “one-size-fits-all” programs
requiring residents to complete identical training
modules across five years.
“As medical care becomes increasingly complex, it’s evident that not every individual needs to
learn the entire breadth of surgery,” Klingensmith
said. “For instance, do trainees going into heart
surgery ever need to do pancreas surgery? Right
now, that is a requirement. But it may not make
a lot of sense in the big picture.”
outlook.wustl.edu

Customizing residency training to individual
aspirations could maximize the experience —
reinforcing select skill sets while decreasing the
dependency on fellowships.
Klingensmith is leading a nine-institution
consortium examining flexibility in surgical training. At participating institutions, residents in their
third, fourth or fifth years may spend 12 months in
specialized rotations that will better prepare them
for their intended areas of practice. The institutions
are evaluating the effectiveness of such a model
and collecting data on resident performance.
Washington University’s general surgery residency was one of the earliest to develop a “fast
track” in cardiothoracic (2005) and vascular
(2006) surgery, allowing senior residents to focus
on these areas. The vascular surgery section took
it a step further in 2013; trainees do not enter a
general surgery residency, but rather spend five
years learning vascular surgery almost exclusively,
with some general surgical skills taught early in
the program.
“Training the next generation of surgeons will
require the types of programs we are developing,
which are intentional, structured, rigorous and
customized,” Awad said. “We no longer can
rely on whatever happens to come through the
operating room doors.”

The Department of
Surgery was among the
earliest to offer a skills
training lab outside
the O.R.

Learn more about general
surgery residency at
Washington University
School of Medicine
gsres.wustl.edu
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Match Day 2015

Doctors learn their futures
THE FIRST DAY OF SPRING, MARCH 20, also was
the day medical students across the country found
out where they will head for their residency programs,
the next stage in their medical careers.
School of Medicine students gathered at the
Eric P. Newman Education Center for the muchawaited delivery of envelopes containing news
of where the soon-to-be graduates had matched.
As students approached the microphone one-by-

CALIFORNIA
Los Angeles
University of California,
Los Angeles
O P H T H A L M O LO G Y

Kirk Hou

R A D I AT I O N O N C O LO G Y

Naomi Jiang

Riverside
University of California, Riverside,
School of Medicine
P S Y C H I AT R Y

Kazuo Omi

Sacramento
University of California,
Davis Medical Center
INTERNAL MEDICINE

Vivian Tien

San Diego
University of California, San Diego
D E R M AT O LO G Y

David Cotter

O B S T E T R I C S  G Y N E C O LO G Y

Sarah Lederhandler

O R T H O PA E D I C S U R G E R Y

Dylan Kluck
P E D I AT R I C S

Leslie Chiang

San Francisco
California Pacific Medical Center
O P H T H A L M O LO G Y

Ann Thomas

University of California,
San Francisco
INTERNAL MEDICINE

Hailyn Nielsen

O R T H O PA E D I C S U R G E R Y

Justin Krogue

San Jose
O’Connor Hospital
FA M I LY M E D I C I N E

Lawrence Zieske

Stanford
Stanford University Programs
EMERGENC Y MEDICINE

Alexander Zozula

INTERNAL MEDICINE

Madeleine Chollet
O T O L A R Y N G O LO G Y

Varun Chalivendra
P E D I AT R I C S / R E S E A R C H
TRACK

Susan Canny

Whittier
Presbyterian Intercommunity
Hospital
FA M I LY M E D I C I N E / T R O P I C A L
MEDICINE

Amber Lin

COLORADO
Aurora
University of Colorado
D E R M AT O LO G Y

Jennifer Barklund

one to announce their specialties and where they had
matched, they each placed $1 in a bin. Tradition has it
that the cash goes to the student whose name is called
last. The students are called randomly, so the loot goes to
the person who had to wait the longest for such big news.
Overall, 123 medical students matched in 22
specialties in a total of 23 states. Top specialties included
internal medicine, pediatrics, obstetrics-gynecology,
orthopaedic surgery and anesthesiology.

DELAWARE
Newark

KENTUCKY
Lexington

MICHIGAN
Ann Arbor

Christiana Care

University of Kentucky
Medical Center

University of Michigan Hospitals

O B S T E T R I C S  G Y N E C O LO G Y

Kristen Kapalka
Chelsea Kebodeaux

DISTRICT OF
COLUMBIA
Washington
Children’s National Medical Center
P E D I AT R I C S

Angelica Wong

FLORIDA
Miami
Jackson Memorial Hospital
P E D I AT R I C S

Temidayo Adebiyi

GEORGIA
Atlanta
Emory University
School of Medicine
INTERNAL MEDICINE

Amirhossein Esmaeeli

CONNECTICUT
Farmington

ILLINOIS
Chicago

University of Connecticut
School of Medicine

Northwestern McGaw
Medical Center

O B S T E T R I C S  G Y N E C O LO G Y

Stephanie Higgins

New Haven
Yale-New Haven Hospital
INTERNAL MEDICINE/
PHYSICIAN SCIENTIST

Sandra Williams
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INTERNAL MEDICINE

Lindsay Forbes

INTERNAL MEDICINE/
D E R M AT O LO G Y

Lida Zheng

Rush University Medical Center
A N E S T H E S I O LO G Y

D I A G N O S T I C R A D I O LO G Y

Leanne Lin

MARYLAND
Baltimore
Johns Hopkins Hospital
INTERNAL MEDICINE

Stephanie Wang

Bethesda
Walter Reed National Military
Medical Center
GENERAL SURGERY

Robert DesPain

MASSACHUSETTS
Boston
Beth Israel Deaconess
Medical Center
INTERNAL MEDICINE

Pankaj Pal

Brigham & Women’s Hospital
INTERNAL MEDICINE

Nicholas Yozamp
U R O LO G Y

Valary Raup

Massachusetts General Hospital

EMERGENC Y MEDICINE

Alexander Beyer

O T O L A R Y N G O LO G Y

Michael Wilson
P E D I AT R I C S

Michael Triebwasser

Detroit
Children’s Hospital of Michigan
P E D I AT R I C S

Tamara Cooks

Wayne State University/Detroit
Medical Center
O B S T E T R I C S  G Y N E C O LO G Y

Sarah Cortez

Royal Oak
Beaumont Health System
O R T H O PA E D I C S U R G E R Y

Kevin Park
Jonathan Wright

MISSOURI
St. Louis
Barnes-Jewish Hospital
A N E S T H E S I O LO G Y

Krisztina Escallier
Bradley Fritz
Maxim Wolfson
D E R M AT O LO G Y

A N E S T H E S I O LO G Y

Leonid Shmuylovich
Christian Wichterman

D I A G N O S T I C R A D I O LO G Y

Kevin Baumgartner
Jarrod Dornfeld

Aaron Rudin
Rachel Steinhorn
Reece Goiffon

EMERGENC Y MEDICINE

GENERAL SURGERY
PRELIMINARY

Gregory Ebersole

David Kim
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INTERNAL MEDICINE

Jordan Atkins
Stephen Chi
Christopher Chung
Nhila Jagadeesan
Joyce Ji
Ramon Jin
Jimmy Ma
Arvind Rengarajan
Anjali Rohatgi
Stephanie Velloze
Peter Zhao

N E U R O LO G I C A L S U R G E R Y

Jacob Greenberg
Bhuvic Patel
N E U R O LO G Y

Elyse Everett
Alan Plotzker
O B S T E T R I C S  G Y N E C O LO G Y

Chelsea Bayer
Katherine Smith
Jennifer Travieso

O R T H O PA E D I C S U R G E R Y

Zachary Meyer
PAT H O LO G Y

Brianna Kolody
Stephen Persaud
P S Y C H I AT R Y

Desiree Baumgartner
Marie Bosch
Allan Jiang
Lauren Marks
Alexander Rose
Max Rosen

St. Louis Children’s Hospital
P E D I AT R I C S

Cori DeSanto
Sarah Ihnen
Natalie Macaruso
Drew Schwartz
Miriam Steinberg
Jessica Tsai
Annie Wang
Julia Warren
Elizabeth Wright-Jin
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St. Louis University
School of Medicine
O R T H O PA E D I C S U R G E R Y

Kelsey Rebehn

Washington University
O P H T H A L M O LO G Y

Han Li
James Liu

NORTH CAROLINA
Chapel Hill

PENNSYLVANIA
Philadelphia

University of North Carolina
Hospitals

Hospital of the University of
Pennsylvania

FA M I LY M E D I C I N E

Alvin Powell

Durham

A N E S T H E S I O LO G Y

Nicole Shin

INTERNAL MEDICINE
RESEARCH

NEW MEXICO
Albuquerque

Duke University Medical Center
O B S T E T R I C S  G Y N E C O LO G Y

Wumesh K.C.
Jonathan Lake

University of New Mexico
School of Medicine

O R T H O PA E D I C S U R G E R Y

Neena Cherayil

PAT H O LO G Y

Samuel Anderson

NEW YORK
Bronx
Einstein/Montefiore
Medical Center
GENERAL SURGERY

Faye Yu

New York Hospital for
Special Surgery
O R T H O PA E D I C S U R G E R Y

Lauren Wessel

New York
New York Presbyterian
Hospital-Columbia
INTERNAL MEDICINE

John Blackett
Judith Kim

Rochester
University of Rochester/
Strong Memorial
O R T H O PA E D I C S U R G E R Y

Wajeeh Bakhsh

Katherine Bishop
Gerald Aggrey

OHIO
Cincinnati
Cincinnati Children’s Hospital
C H I L D N E U R O LO G Y

Adrienne Brower-Lingsch

University of Cincinnati
O P H T H A L M O LO G Y

Carl Bruce

Cleveland
Cleveland Clinic-Cole Eye Institute
O P H T H A L M O LO G Y

Robert Purgert

Columbus
Ohio State University
Medical Center
O B S T E T R I C S  G Y N E C O LO G Y

Rahel Ghenbot

OKLAHOMA
Oklahoma City
University of Oklahoma
College of Medicine
O B S T E T R I C S  G Y N E C O LO G Y

Emily Zantow

N E U R O LO G Y

Pittsburgh
University of Pittsburgh
Medical Center
GENERAL SURGERY

Amelia Lucisano
P E D I AT R I C S

Elise Lu

PLASTIC SURGERY
 I N T E G R AT E D 

Lucas Dvoracek

RHODE ISLAND
Providence
Rhode Island Hospital/Brown
University
O R T H O PA E D I C S U R G E R Y

Steven Bokshan

TEXAS
Edinburgh
University of Texas
Health Science Center
INTERNAL MEDICINE

Chi Lun Pui

Houston
Baylor College of Medicine
PHYSICAL MEDICINE &
R E H A B I L I TAT I O N

Uzoh Ikpeama

University of Texas
MD Anderson Cancer Center
R A D I AT I O N O N C O LO G Y

Adnan Elhammali

San Antonio
University of Texas
Health Science Center
O B S T E T R I C S  G Y N E C O LO G Y

Vaishnavi Purusothaman

WASHINGTON
Seattle
University of Washington
Affiliated Hospitals
P E D I AT R I C S

Katharine Walz
PLASTIC SURGERY
 I N T E G R AT E D 

Grace Um

WISCONSIN
Milwaukee
Aurora St. Luke’s
Medical Center
D I A G N O S T I C R A D I O LO G Y

Nyabosamba Binagi

Medical College of Wisconsin
Affiliated Hospitals
O T O L A R Y N G O LO G Y

Miranda Colletta

PLASTIC SURGERY
 I N T E G R AT E D 

Adam Aronson

Choosing to defer residency:
Carolyn Purgert
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Leading Together

The Campaign for Washington University

New name,
new era
The Elizabeth H. and James S.
McDonnell III Genome Institute
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G E N O M I C S - B A S E D R E S E A R C H is opening
the door to more precise diagnoses, new disease
treatments, and the ability to understand people’s
health needs based on their genetic makeup. In the future,
ROBERT BOSTON

individualized DNA analysis
will lead to a powerful form
of preventive medicine.
To help support this
paradigm shift in medicine,
civic leaders and longtime
philanthropists Elizabeth H.
and James S. McDonnell III
pledged $25 million to The Genome Institute, which will
be renamed the Elizabeth H. and James S. McDonnell III
Genome Institute at Washington University.

The Genome Institute’s Richard
K. Wilson, PhD; Li Ding, PhD;
Elaine Mardis, PhD; and Robert
Fulton are among the world’s
researchers most often cited
in scientific publications.

“This extraordinary gift will enable our top-line
researchers to set more ambitious goals and step up
discoveries in the fast-paced world of genomics,” said
Washington University Chancellor Mark S. Wrighton.

outlook.wustl.edu
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Lukas Wartman, MD, a leukemia
doctor and researcher, developed
the disease himself. Colleagues
sequenced his cancer genome
and instead treated him with a
kidney cancer drug. Without the
sequencing data, doctors say he
likely would not have survived.

Tracing the roots of disease

Under the leadership of Director Richard K. Wilson, PhD,
the Alan A. and Edith L. Wolff Distinguished Professor of
Medicine, and Co-director Elaine Mardis, PhD, the Robert E.
and Louise F. Dunn Distinguished Professor of Medicine, the
institute is helping to transform medicine using genomics.
Founded in 1993, the institute played a key role in the
Human Genome Project, an international effort to decode
all 6 billion letters of our genetic blueprint. It ultimately
helped decode, or sequence, 25 percent of the genome by
the project’s completion in 2003. The institute also has

pioneered whole genome sequencing as a way to study cancer
and other diseases.
In 2008, using private funds, institute researchers became
the first to decode the whole genomes of both healthy and
tumor cells from a leukemia patient — tracing the disease to
its genetic roots. This potent mix of technology and ingenuity ushered in a new era, enabling researchers to search the
entire genome to identify possible cancer-causing mutations.
Even though the institute is one of only three National
Institutes of Health (NIH)-funded, large-scale sequencing
centers in the U.S., it has struggled to find funding for some

ROBERT BOSTON

Solving a 6-billion-piece puzzle
Twins streamline the “big data” of genetics to aid clinical care
Obi Griffith, PhD, and Malachi Griffith, PhD

A

s sequencers churn out human
genome data faster, and
researchers better understand
which “mistakes” in the genetic code
lead to disease, a question remains:
how to interpret and catalog the
6 billion letters of our genetic code
so that clinicians can use it?
Obi Griffith, PhD, and Malachi Griffith,
PhD, are identical twins and members
of the McDonnell Genome Institute.
They are streamlining information for
clinicians and patients to aid in disease
diagnosis and potential drug therapies.

28 Washington University School of Medicine

The brothers’ interest in pairing drugs
with genetics is as much personal as it
is scientific. Their mother died of breast
cancer just weeks before they graduated
from high school.
“The more data the better,” said
Malachi Griffith, assistant professor of
genetics in bioinformatics and associate
director at the institute. “But our current
capacity to deal with it means that it
can often seem like too much to handle.
The data is incredibly complex, and a
lot of it is still unfamiliar to people
practicing medicine.”

To date, the brothers and a team of
software developers have launched two
open-source websites, the Drug-Gene
Interaction Database (dgidb.genome.
wustl.edu) and the Database of Curated
Mutations (docm.genome.wustl.edu).
“With these tools, oncologists don’t
have to read 100 papers,” said Obi
Griffith, assistant professor of medicine
and assistant director at the institute.
“They can just get the final end product,
the recommendation or the actionable
statement.”

Spring 2015

of its riskier projects. Sequencing the first whole cancer
genome was a tough sell, as it was thought to be too expensive and too risky, possibly without much immediate benefit.
The McDonnells, who lost their daughter, Peggy, at age
2 of neuroblastoma, a common cancer in children, have
long supported pediatric cancer research. “What appeals
to us about the institute is its collaboration with St. Louis
Children’s Hospital, Washington University School of
Medicine’s Department of Pediatrics and others in the
application of genomics to pediatric cancers,” said James
McDonnell III.
In 2010, to better understand the genetic origins of
pediatric cancer, the institute launched the St. Jude
Children’s Research Hospital-Washington University
Pediatric Cancer Genome Project. The project has led to the
whole genome sequencing of more than 1,000 childhood
cancer patients, helping to pinpoint a variety of mutations,
including a key mutation in pediatric neuroblastoma.
Over the past six years, cancer genomics studies at the
institute have compared the tumor and normal genomes
in patients with breast, liver, kidney, brain, lung, skin and
blood cancers, among others.
“At some point, we’ll be able to look at many different
patients with the same type of disease and start to understand what’s genetically similar about all these people’s diseases and what’s different,” Wilson said. “That information
eventually will lead to the development of new treatments.
But even in the short term we can use that information to
more effectively utilize the drugs we already have on the
shelf right now.”

Precision therapy

In one clinical study, Lukas Wartman, MD, a patient
with leukemia, had relapsed twice and run out of options.
Institute researchers sequenced his genome and discovered
a mutation that might be treatable instead with a kidney
cancer drug already on the market. Wartman, who is now
an assistant professor in the Department of Medicine and an
assistant director at the institute, took the drug and was able
to attain remission, allowing him to receive a stem cell transplant. Without the sequencing data, Wartman’s doctors say
he likely would not have survived.
“Soon, we’re going to see an era where patients are monitored much more closely, their diagnoses are much more
precise and individualized and, hopefully, their outcomes are
much better,” Mardis said. “Side effects will be diminished.
The days of one-size-fits-all therapeutics will be gone.”
To fulfill the promise of putting genomics into clinical
practice, Wilson said, philanthropy is crucial.
“There is not a lot of support at this time for clinical
genomic testing of cancers because it’s still in its infancy,”
he said. “To take it to the next level and really touch more
patients, we’ve got to have gifts like the McDonnells bring.”
outlook.wustl.edu
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McDonnell Pediatric
Research Building

Elizabeth H. and James S. McDonnell III have
championed research efforts at the School of
Medicine for many years.
In 2000, together with Anne, AB ’64, and
John F. McDonnell and the JSM Charitable Trust,
they funded the construction of the McDonnell
Pediatric Research Building. The building was
dedicated in memory of their daughter,
Peggy, who died of cancer in 1972 at age 2.
In 2009, they endowed the Elizabeth
H. and James S. McDonnell III Distinguished
Professorship, which was instrumental in
bringing Dennis Hallahan, MD, a preeminent
figure in the study of cancers of the brain and
central nervous system,
to Washington University.
“Libby and Jim’s
philanthropy has
spawned scientific
discoveries in nearly every pediatric
discipline,” said Larry J. Shapiro, MD,
executive vice chancellor and dean of the
School of Medicine. “They have championed
the medical school for many years, and this
gift demonstrates their exceptional dedication to ensuring success in many key areas.”
McDonnell’s father, James S. McDonnell Jr.,
made a gift in the 1960s to establish the
McDonnell Medical Sciences Building. In
1968, he endowed the James S. McDonnell
Professorship in Genetics. And, in 1975,
he made a gift to create the James S.
McDonnell Department of Genetics, one
of the first genetics departments within a
U.S. medical school.

Family
legacy
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scholarships

BY HILARY DAVIDSON

Shirley Sahrmann,
PT, PhD, with
scholarship
recipients
Stacy Jackson
and Matthew
Mastenbrook.

The promise of tomorrow

W

ith support from generous alumni, Washington

The School of Medicine
attracts some of the world’s
best and brightest students.
Scholarships provide the

University is helping a new generation of aspiring

medical professionals minimize student debt.

More than 80 percent of its medical students receive

financial aid, primarily in the form of scholarships.
“We’ve always tried to see that anyone who has the
ability and the desire to be a student at Washington

tools they need to

University is given the opportunity,” said Larry J. Shapiro, MD,

change the world.

executive vice chancellor for medical affairs and dean of the
School of Medicine. “We’re proud of the fact that our medical
students have among the lowest debt of any medical students
in the country,” he said.
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Psychology of scholarships

Scholarships are a top priority for Gammon
Earhart, PT, PhD, director of the Program in
Physical Therapy.
“We want to continue to attract the best and
the brightest physical therapy students, and to do
that we need to be sure that they have the support
they need,” she said. “That includes support from
our faculty and staff for academic endeavors, but
also financial support so they know that they can
graduate with a manageable debt load,” she said.
Scholarships also have psychological benefits,
Earhart said. “Students who receive scholarships
feel welcomed. They feel like we have identified
them as the best of the best and that we really
want them to be here.”
Matthew Mastenbrook, DPT ’17, would agree.
“I really want to work hard to show that I deserve
the scholarship, and that I can make the person
who gave it proud,” he said.
Shirley Sahrmann, PT, PhD, professor emerita
of physical therapy, has created two scholarships,
including the one awarded to Mastenbrook, and
plans to create more as she leads fundraising
efforts among alumni.
Sahrmann wants to help talented students
“be at peace” with the choices they have made, and
live their lives without the worry of student debt.
Sahrmann said that the program’s strong
research component, an outgrowth of collaborations with the medical school, offers students the
opportunity to “do incredible things.” “Students
are exposed in every which way to people who
are on the cutting edge.”
Such a dynamic environment can’t help but
produce top practitioners and leaders, she said.
“I get to travel around the country, and I’m always
so pleased when I hear from clinicians saying,
‘Oh, we hired one of your amazing graduates,’”
Sahrmann said.
“To think I can play some little role in helping
people get on with their lives not only as professionals, but also in their personal lives, is really
important to me.”

Reasons for giving

Retired Col. William P. Wiesmann, MD ’72,
president and CEO of bioSTAR Inc., created
scholarships because he wants others to “experience the wonderful things” he experienced at
Washington University.
“When I came as a freshman I could get into
a laboratory right away and start doing research
with some very wonderful people,” he said.
outlook.wustl.edu

“I had the chance to do some really fundamental
basic science. I was able to write papers in medical
school, which was a fantastic opportunity for me.
It set me on my career path at that point.”
Wiesmann spent the majority of his career as
a research scientist for government organizations
such as NASA, and later became an entrepreneur.
“I’ve been looking back and thinking, ‘What
were the things that made a difference in my life,
and allowed me to get to where I am?’” Wiesmann
said. “Some of those things have to do with being
free to do what you want to do — being free to be
passionate about what you love to do.”
A full-tuition scholarship enabled Vernetta
Harris, MD ’04, to graduate from the School
of Medicine with relatively little debt. Harris

Degrees of debt
Scholarships and financial aid help Washington University School of Medicine students
graduate with far less debt on average compared to students at other medical schools.
AVERAGE AMOUNTS OF STUDENT DEBT

$200,000

$181,058 Private
$162,736 Public

$160,000
$120,000
$80,000

$91,124
’05

’06

’07

’08

’09

’10

’11

’12

began practicing medicine in Atlanta, and eventually became a medical director of an emergency
department in Tennessee. Being on sound financial footing allowed her to make the move, she
said. “I felt like I was empowered to make changes,
some call it risk, without thinking of the financial
consequences.”
Harris also took some time off from clinical
practice to participate in relief efforts in Ghana
and Jamaica. “I would not have been able to do
that so early in my career if I had had a large
amount of financial stress.”
Harris funds scholarships to help others in
the way she was helped.
“I know how big a boost and blessing it was
to me, and I wanted to provide that to other
students. Hardworking, talented students
should be rewarded.”

’13

WUSM

’14

Scholarship support
helps deserving
students succeed.
LEARN MORE

(314) 935-9691
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BY HILARY DAVIDSON

Against Alzheimer’s disease

R

odger and Paula Riney know all too well the
devastating effects of Alzheimer’s disease.
“My mother struggled with it for quite a long
time,” said Rodger Riney, the founder and CEO of Scottrade,
a nationwide discount retail brokerage firm. “It was just
the most awful thing to watch.”
Paula Riney has a similar story. “My dad passed away
just over three years ago after battling Alzheimer’s for 12
to 13 years,” she said. “It was one of the saddest things I’ve
ever experienced.”
The couple became involved with the Alzheimer’s
Association, St. Louis chapter, and ultimately decided to
make a significant investment toward research.
“We felt that we wanted to do something a little more
substantive,” Rodger Riney said. “Certainly something needs
to happen because the cost of Alzheimer’s on society is just
devastating and it doesn’t get the attention of other diseases.”
“We just felt like we needed to do more,” added Paula Riney.
The couple discussed various initiatives of the university’s Charles F. and Joanne Knight Alzheimer’s Disease
Research Center (Knight ADRC) with its director, John C.
Morris, MD, the Harvey A. and Dorismae Hacker Friedman
Distinguished Professor of Neurology. The Rineys decided
to support School of Medicine researcher Beau Ances,
MD, PhD, who they previously had met at an Alzheimer’s
Association event.

“We thought he was a terrific guy,” said Rodger Riney.
Ances, an associate professor of neurology affiliated with
the Knight ADRC, is seeking biomarkers and developing
imaging techniques to help researchers visualize amyloid
and tau deposits in the brain. These protein deposits are
hallmarks of Alzheimer’s. Amyloids form clumps outside
of brain cells that disrupt neural networks, Ances said,
while tau deposits form “tangles,” which twist and destroy
communication pathways.
Studies by the Knight ADRC have shown that tau and
amyloid can start to show up in the brain 15 to 20 years
before symptoms manifest.
“A lot of changes go on in this early preclinical phase,”
Ances said. “Even though the individual is very normal,
he or she already has pathology.”
While amyloid imaging has been used extensively in
Alzheimer’s research studies, Washington University is
one of the few sites worldwide that can image tau. These
tau deposits can be viewed with labeled radioisotopes
and a PET scanner, Ances explained.
Better imaging techniques will help researchers pinpoint
the disease mechanisms, he added, and identify therapies
that could stop the disease or delay onset.
“My biggest hope is that we could find something to
stop it in its tracks,” said Paula Riney.

Furthering efforts to
mitigate the impact
of Alzheimer’s disease
David M. Holtzman, MD, the
Andrew B. and Gretchen P. Jones
Professor and head of the
Department of Neurology,
Paula and Rodger Riney, and
Beau Ances, MD, PhD, associate
professor of neurology.
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Rineys honor their parents through commitment to research

classnotes
1940 S
Elliot Luby, MD 49, received a
Distinguished Service Award from Wayne
State University School of Medicine
in Detroit for his 60 years of training,
research and clinical care at the institution.

1960 S
George Bohigian, HS 69, LA 61,
gave the Charles A. Snyder Lecture at the
annual meeting of the Cogan Ophthalmic
History Society in Monterey, Calif. He is a
professor of clinical ophthalmology and
visual sciences at WUSM.

1970 S
Susan Cigelman, PT 76, recently retired
as vice president for academic affairs at
AIB College of Business in Des Moines,
Iowa. Prior to this position, she served
as director of the physical therapy
program at Des Moines University from
1987 to 2003.
David Dooley, MD 79, continues his
responsibility with resident, fellow and
medical student education at the South
Texas VA and University Hospital. He also
teaches internal medicine and infectious
diseases to trainees.

1980 S
Gina Musolino, PT 87, was re-elected
to a second term as Florida chief delegate to the American Physical Therapy
Association, House of Delegates.
John Constantino, MD 88, was awarded
the 2014 Irving Phillips Award for
Prevention from the American Academy
of Child & Adolescent Psychiatry for significant contributions to the prevention of
mental illness in children and adolescents.
He is the Blanche F. Ittleson Professor of
Psychiatry and Pediatrics at WUSM.
Andrew Sonin, MD 88, LA 84, was
inducted as a fellow in the American
College of Radiology. He is a diagnostic
outlook.wustl.edu

radiologist and a clinical assistant
professor of radiology at the University
of Colorado.

1990 S
Dale Horne, MD 90, LA 82, recently
accepted a position with the Mayfield
Clinic & Spine Institute in Cincinnati. He is
a board member and past president of the
Ohio State Neurosurgical Society, secretary
of the Northwest Quadrant of the Council
of State Neurosurgical Societies, and a fellow of the American College of Surgeons.
Jeff Boris, MD 91, is a clinical professor of pediatrics at the University of
Pennsylvania and a pediatric cardiologist
in the outpatient clinic and director of the
Postural Orthostatic Tachycardia Syndrome
Program at Children’s Hospital of
Philadelphia. He also chairs the American
College of Cardiology Foundation/
American Heart Association Task Force for
Data Standards for the Electronic Health
Record, specific to pediatric and congenital cardiology.
Grant Hoekzema, MD 92, was named
chair of the Council of Academic Family
Medicine in 2013-14 and recently
completed a term as president of the
Association of Family Medicine Residency
Directors. He is program director for
Mercy Family Medicine-St. Louis.

2000 S
Stefan Schulz, PT 01, is lead ergonomist
with Briotix, a workforce performance
company.
Laura VanZandt, OT 08, was married
Aug. 30, 2014.

I M
A LU M N I

Edna Dependahl, NU 45
Dependahl died Tuesday, Dec. 9, 2014.
She was 91. Dependahl worked at
Normandy Osteopathic Hospital for many
years. An avid gardener, she was a docent
at the Missouri Botanical Garden for 45

years. She was married to the late Eugene
Dependahl for 50 years. Dependahl is
survived by children Deborah, Frances
and Carol; and three grandchildren.
Birkle Eck, MD 42, LA 38
Eck died Wednesday, Sept. 17, 2014. He
was 97. During undergraduate study
at Washington University, he served as
class president and did so again while at
WUSM. After finishing a medical degree,
Eck joined the U.S. Army, serving in Africa,
Italy and Japan and achieving the rank of
major before leaving active duty service
in 1945. He served a residency at the VA
Medical Center at Jefferson Barracks. He
later opened a private practice in Clayton,
Mo., and served on the Deaconess
Hospital staff. The last 10 years of his
career were spent as medical director
at Mari de Villa Retirement Center. He is
survived by his wife of nearly 53 years,
Mary Lea Eck.
Albert Eisenstein, MD 44
Eisenstein died Thursday, Dec.18, 2014.
He earned a bachelor’s degree from the
University of Missouri before attending
WUSM. During World War II, he was a U.S.
Army captain. Before moving to New York
in 1968, Eisenstein served as professor
of medicine at Washington University
and chief of internal medicine at Jewish
Hospital. In New York, he served as professor of medicine at Downstate Medical
School and chief of internal medicine
at Gouveneur Hospital. After retiring
to Florida, he became volunteer physician and medical director of the Senior
Friendship Center for about 30 years.
Eisenstein is survived by his wife of 73
years, Barbara; five children, Robert, Sylvia,
Lesley, James and Richard; and 11 grandchildren and 17 great-grandchildren.
Harry Allen Fozzard, MD
Fozzard, a pioneer in the study of cardiac
muscle activity and the Otho S.A. Sprague
Distinguished Professor Emeritus in the
Department of Medicine at the University
of Chicago, died Tuesday, Dec. 9, 2014.
He was 83. He attended Washington &
Lee University and WUSM and interned at
Yale University. He served in the U.S. Navy
Corps at Camp Lejeune in 1957-59 and
remained in the reserves, retiring in 1969
Outlook 33
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as lieutenant commander. He completed
his internal medicine residency and cardiology training at Washington University
and obtained his research training in
cardiac electrophysiology at the University
of Bern, Switzerland. After several years
in St. Louis, he joined the faculty of the
University of Chicago in 1966. His special
clinical interest was cardiac arrhythmias,
and he was a pioneer in the establishment
of coronary care units, use of beta blockers
in management of myocardial infarction,
computerized rhythm monitoring, and
invasive cardiac electrophysiology. His
basic research was on the biophysics of
cardiac rhythm, leading to 160 experimental articles, 60 reviews and editorials and
several books. He was vice president of
the American Heart Association, editorin-chief of the AHA Journal Circulation
Research, AHA Distinguished Scientist, and
member of multiple National Institutes of
Health review panels. An honorary doctorate was awarded to him in Montevideo,
Uruguay, where he was a Fulbright Scholar,
and he was a member of the U.S.-U.S.S.R.
scientific exchange program in medicine
1983–1998. He was elected to the honorific
American Society for Clinical Research and
the Association of American Physicians, and
fellowship in the American Association for
the Advancement of Science. Perhaps his
greatest legacy in science was his mentorship of some 60 graduate students and
postdoctoral trainees, most of whom now
teach in universities around the world. He
is survived by his wife of 61 years, Lyn; two
sons, Richard and Peter; his four grandchildren; his brother, George; and his nephew.
Guy Harper, MD 52
Harper died Sunday, Aug. 24, 2014. He
was 91. Born in Steele, Mo., Harper served
in the European Theater from 1943 to
1945 during World War II. He graduated
from the University of Missouri before
attending WUSM. Harper completed an
internship and residency at Methodist
Hospital of Indianapolis, Ind., before
beginning a private practice as a family
physician in Charleston, lll. He is survived
by his wife of 62 years, Dorothy; children,
Chrys, Robin, Reg, Jill and Roy; 10 grandchildren; and brother, Bobby Joe.
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Betty Owen Knoblock, NU 51
Knoblock died Saturday, Oct. 25, 2014.
She was 85. Born in St. Louis, she
attended Iowa State University before
achieving a nursing degree at Washington
University. She was a head nurse at Barnes
Hospital and met future husband, Dr.
James Owen Jr. After the couple moved
to Oklahoma, Knoblock suspended her
nursing career to be a full-time mother
and volunteer. She was president of the
Service League and a longtime member
of First Presbyterian Church of Bartlesville.
Several years after the death of her husband, she married Richard Knoblock, who
also preceded her in death. Knoblock is
survived by her three sons, Jim, John and
David; three daughters from her second
marriage, Jane, Susan, and Trish; and
nine grandchildren, as well as many
nieces and nephews.
Edgar Nathaniel Lockett Jr., MD 45
Lockett died Monday, Oct. 20, 2014. He
was 93. Lockett served as medical officer
in the U.S. Navy during World War II. He
later was a surgeon at the VA Hospital in
Marion, Ill., and practiced internal medicine at the VA Hospital in Lake City, Fla.
He was proud to serve as chairman of
the deacons and Sunday school director
at his church. His wife of 56 years, Helen,
preceded him in death. He is survived
by his sister, Kathryn; sons, Edgar, John,
David and Jerry; nine grandchildren and
12 great-grandchildren.

I M
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Herman Eisen, MD
Eisen, head of the Department of
Molecular Microbiology at WUSM from
1961-1973, died Sunday, Nov. 2, 2014.
He was 96. Eisen earned a medical degree
from New York University in 1943 and
was a member of its faculty from 195055. He came to Washington University
in 1955 as a professor of medicine in the
Division of Dermatology. Eisen authored
the immunology section of an influential 1970s textbook on microbiology for
medical students. He retired in 1989 from
Massachusetts Institute of Technology,
but, as a professor emeritus of biology,
maintained an active lab at the university.
As head of the Department of Molecular
Microbiology at Washington University,
Eisen oversaw the recruitment of several
faculty members and supervised the
department’s move to the McDonnell
Medical Sciences Building in 1970.
Among his survivors is his wife, Natalie.
John “Jack” Gilster, DE 44
Gilster, professor emeritus of pediatric
dentistry at Washington University School
of Dentistry, died Wednesday, Aug. 6,
2014. He was 92. Born in Chester, Ill.,
Gilster graduated from the University
of Illinois in 1940 and the Washington
University School of Dentistry in 1944.
Summer
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He served two years in the U.S. Army
and three years in a general practice in
Illinois before establishing a private practice in pediatric dentistry. He joined the
Washington University faculty in 1950 and
taught pediatric dentistry until his retirement in 1987. During that time, he also
served on the American Board of Pediatric
Dentistry, as president of the North
District of the St. Louis Dental Society
and as president of the Missouri Society
of Dentistry for Children. He was named
a Distinguished Alumnus of Washington
University in 1987. After retirement, he
moved to Albuquerque, N.M. Gilster is
survived by his children, John, Norman
and Elisabeth, and six grandchildren.
David B. Gray, PhD
Gray, a professor of occupational therapy
and neurology who worked tirelessly
to improve the lives of people with disabilities, died Thursday, Feb.12, 2015.
He was 71. Gray became motivated to
change what it means to be disabled after
he was paralyzed in 1976 in a fall from a
roof that broke his neck. He went on to
work for several agencies at the National
Institutes of Health (NIH), was appointed
director of the National Institute on
Disability and Rehabilitation Research
by President Ronald Reagan and was an
important advocate for the Americans
with Disabilities Act of 1990. He was present when President George H.W. Bush
signed the bill into law. Gray joined the
School of Medicine faculty in 1995 to conduct research and teach courses on social
issues and disability. He was the visionary
behind the internationally recognized
Enabling Mobility Center, now called the
Health and Wellness Center, located at
Paraquad, an independent living center
in St. Louis. Gray was passionate about
developing personalized interventions to
help individuals fully participate in their
everyday life activities. His work on the
role that the environment can play in
determining whether a person with disabilities can fully participate in an activity
is internationally recognized. Realizing
unemployment was a major problem
for people with mobility limitations, he
developed a program to study people
with disabilities who had been successoutlook.wustl.edu

fully employed for two years. He created
videos to tell their stories and made the
videos available to potential employers.
Additionally, Gray developed programs
for parents with mobility limitations.
Gray was born in Grand Rapids, Mich. He
graduated from Lawrence University in
1962 with a bachelor’s degree in psychology. Gray later earned a master’s degree
in experimental psychology from Western
Michigan University, in 1970, and a doctorate in psychology and genetics from
the University of Minnesota, in 1974.
Survivors include his wife of 47 years,
Margaret “Margy”; his son, David; two
daughters, Elizabeth and Polly; a sister,
Priscilla; two brothers, Fred and William;
and two grandchildren.
James P. Keating, MD
Keating, a meticulous physician who
helped mold hundreds of medical residents, organized the first pediatric intensive care unit west of the Mississippi and
was sought for his ability to solve mystery
illnesses, died Thursday, Dec. 25, 2014, in
Cary, N.C. He was 76. Keating, a professor
emeritus of pediatrics at WUSM and the
inaugural W. McKim Marriott, MD, Chair in
Pediatrics at St. Louis Children’s Hospital,
died from a pulmonary embolism. In a
career spanning 44 years at the university
and St. Louis Children’s Hospital, Keating’s
impact was far-ranging. In 1971, he established the pediatric gastroenterology and
nutrition division in the Department of
Pediatrics and served as its director until
1992. Recognized as one of that field’s
founders, Keating helped develop many
now-standard approaches to patient care.
As an early proponent of pediatric intensive care, Keating shaped the first pediatric intensive care unit in St. Louis and was
its director from 1980-1992. Keating also
pioneered the concept of pediatric diagnostic medicine, founded such a division
in 1992 and served as its director until his
retirement. Digging for elusive answers in
medicine was a passion. Keating and his
colleagues discovered a significant cause
of water intoxication — a potentially
fatal condition — in infants. They found
that 3- to 6-month-olds living in poverty
suffered the illness disproportionately
because their caretakers were more likely

to run out of formula and instead feed
infants water. Keating’s position as director
of the pediatric residency program, which
he held from 1969-2002, was among the
roles he loved most. A demanding teacher,
he was both feared and revered by the
legions of residents he trained. Keating
was born in Braddock, Pa. His father was
killed in a mill accident when Keating
was 11, leaving his mother to raise four
children. Keating earned an academic
scholarship to Harvard, where he went
on to receive an undergraduate degree
and attend Harvard Medical School. He
worked at Massachusetts General Hospital
and then served as a U.S. Navy lieutenant
at a civilian hospital in Vietnam during
the Vietnam War. Among other honors,
he received the Navy Commendation
for Valor. After retiring in 2012, Keating
moved to North Carolina. His survivors
include his wife, Susan; daughter, Amy;
son, Thomas; sister, Mary; and brothers,
Larry and Jerry.
Herbert Rosenbaum, HS 51
Rosenbaum, professor emeritus of neurology at WUSM, died Wednesday, Dec.
10, 2014. He was 90. Distinguished as
a clinical neurologist, diagnostician,
outstanding teacher and dedicated supporter of Washington University and
Barnes-Jewish Hospital, Rosenbaum was
widely respected for his contributions
to students and trainees. He taught the
Practice of Medicine course for 61 years
and mentored many residents during
his tenure. Rosenbaum attended the
University of Oregon for bachelor’s and
medical degrees before completing residency and training at Barnes Hospital.
He served for two years as a neurologist
in the U.S. Air Force during the Korean
War before joining WUSM faculty in
1954. Rosenbaum was a member of the
American Academy of Neurologists and
the Clinical Society of Neurology. He was
awarded the Distinguished Service Award
by the Washington University Medical
Alumni Association in April 2014. Survivors
include his wife, Velma; children, Robert,
Barbara and Nancy; stepdaughter, Diana;
and several grandchildren and stepgrandchildren.
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John C. Morris, MD
Harvey A. and Dorismae Hacker Friedman Distinguished
Professor of Neurology; Director, Charles F. and Joanne Knight
Alzheimer’s Disease Research Center
Childhood dream:
To play for the Cleveland Browns in the National Football League
Guess that didn’t work out. What did?
Wrestling — Athletic Hall of Fame inductee, Ohio Wesleyan University
What are you most grateful for?
After my family, it is all the talented faculty, staff and dedicated
volunteers of the Knight ADRC!
Favorite honor:
One award with great personal significance is the Dr. Neville Grant
Award for Clinical Excellence from Barnes-Jewish Hospital and
Washington University Physicians. It means my peers
consider me a good doctor!
Proudest moment:
Most recently it is the birth of my first grandchild,
Jack, as he represents the next generation of
what is most important — my family.
I support the School of Medicine because:
Washington University has been so
supportive of me, and I am most
pleased to give back.

Like Dr. Morris, consider supporting
Washington University School of
Medicine through an estate gift,
life income plan or other planned gift.
To learn more, visit plannedgiving.wustl.edu
or call 800.835.3503.

Consult with your legal or tax adviser before making a charitable gift.
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Dissecting
Vesalius
BERNARD BECKER MEDICAL LIBRARY

Online exhibit:
beckerexhibits.wustl.edu/
vesalius
Video — Faculty discuss
Vesalius’ lasting impact:
wumcnews.org/vesalius

Marking 500 years since the birth of Andreas Vesalius,
the father of modern anatomy, Washington University and
Saint Louis University co-hosted an interdisciplinary symposium.
The three-day event included a roster of internationally
renowned speakers and a dramatic re-creation in the Eric P.
Newman Center — complete with an actor in a cadaver suit.
Above, performers portray the intellectual struggle between
25-year-old Vesalius and aged professor Matthaeus Curtius.
Authorities such as Curtius revered the writings of ancient
Greek physician Galen. Vesalius instead championed “the body
over the book.” His inquiring mind would come to define a
new era of anatomical exploration.
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Voices heard
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KAVON JAVAHERIAN

First- and second-year medical students
recently met with legislators at the Missouri State Capitol in Jefferson City.
The cohort discussed issues of importance to the next generation of doctors.
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